Johns Hopkins University: Alcoholism trials
The registry lists 15 Alcoholism studies with Johns Hopkins University as lead sponsor. 7 are open to participants now and 4 have results posted.
Phase 1 2Phase 2 7Phase 3 1Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Daridorexant for Alcohol Use DisorderNot yet recruitingNCT07532252Phase 2
- Peer Support for Liver Transplant Recipients With History of ALDRecruitingNCT07397598Not applicable
- Combination Therapy for Alcohol Use DisorderNot yet recruitingNCT07249554Phase 2
- Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and CravingRecruitingNCT07148843Phase 2/3
- Cerebellar Involvement in Alcohol Use Disorder (AUD)RecruitingNCT05732207Not applicable
- Alcohol Research in HIV: Relapse PreventionRecruitingNCT05163301Not applicable
- Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAHRecruitingNCT03845205Not applicable
- INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy DrinkersCompletedNCT02989662Phase 1/2Results posted
- Treatment Engagement With Technology-assisted TreatmentCompletedNCT02674477Not applicableResults posted
- Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ PersonsCompletedNCT01254877Phase 2Results posted
- Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive WomenCompletedNCT00127231Not applicableResults posted
- Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use DisorderActive, not recruitingNCT04620759Phase 2
- Laboratory Studies on Oxytocin for Treatment of Alcohol Use DisorderCompletedNCT02407340Phase 1
- A Therapeutic Workplace for Alcohol DependenceCompletedNCT00183144Phase 2
- Naltrexone Treatment for AlcoholismCompletedNCT00000438Phase 4